Kailee Rainse / startuprise - SignaCor Therapeutics, a Belfast-based HealthTech startup, has received €288k (£250k) in funding from VC firm Zinc to advance the development of a new treatment designed to repair heart damage and slow hypertrophic cardiomyopathy (HCM). The investment is …
Back to Top / Tuesday, March 10, 2026, 10:21 am / permalink 20455 / 3 stories in 25 hrs
Uber expands gender-preference options allowing riders and drivers to avoid men / 46 hrs
Uber liable in $8.5M sexual assault case sparks precedent lawsuits / 4 wks
Remedy Acts on FBC: Firebreak After Launch Backlash / 8 months
Uber Launches New Rush Hour Pool Service With a Twist / 9 months
TikTok US rolls out hyper‐local “Local Feed” feature / 27 days
Lyft Debuts New Teen Accounts with Enhanced Safety Protections for Young Riders / 4 wks
Itch.io deindexes NSFW content amid payment partner pressure / 7 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.